The report on Immunotherapy Drugs Market by Infinium Global Research analyzes over the period of 2017 to 2013. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Immunotherapy Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Immunotherapy Drugs Market.
The size of the global immunotherapy market was approximately USD 108.5 billion in 2016. The global immunotherapy market is projected to reach USD X.XX billion by 2023, growing with a CAGR of 13.5 % to 14.0% from 2017 to 2023.
Immunotherapy is a biological therapy, which harnesses the ability of the immune system of a human body for combating a disease or an infection. Immunotherapy techniques either involve stimulation of immune system to work smarter against the attack of cancer cells or induction of artificial immune system proteins or some other immune system components to improve the immunity. Immunotherapy is an alternative treatment for multiple type of cancers such as brain, bladder, breast, cervical, colorectal, gastric, kidney, lymphoma, leukemia, lung, ovarian, prostrate and melanoma. In the case of cancer, immunotherapy helps in slowing or stopping the cancer cells growth, stops spreading of cancer to other regions of the body and stimulates the immune system to destroy the cancer cells effectively. Adoptive T-cell transfer, adjuvant immunotherapy, checkpoint inhibitors, cytokines, monoclonal antibodies, therapeutic cancer vaccines and oncolytic virus immunotherapy are some of the types of immunotherapy. Immunotherapy is also termed as living drug, as the t-cells from the patients are re-engineered for creating special antigen receptors. Moreover, immunotherapy is also useful treatment for autoimmune disease, combined immunodeficiency, inflammatory diseases and some other biological infectious diseases.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/312
Segments Covered:
The report segments the global immunotherapy market by product, disease condition and region. On the basis of product, the market is segmented as monoclonal antibodies, checkpoint inhibitors, vaccines, inferon’s and others. Based on disease condition, the market is segmented as cancer, infectious disease, autoimmune disease, and others. Cancer segment has the highest share in the global immunotherapy drugs market as a majority of the drugs available are for various cancer treatments. Increasing demand for monoclonal antibodies, due to its effectiveness in dealing with specific cells or areas with disease is expected to drive the demand for immunotherapy drugs. Moreover, effectiveness of monoclonal antibodies in other therapies is expected to enhance the growth of the global immunotherapy market significantly. The increasing acceptance of low-cost biosimilars of popular biological immunotherapy drugs is also expected to drive the growth of the global immunotherapy drugs market. Furthermore, increasing number of patients with autoimmune diseases is expected to drive demand for immunotherapy drugs during the forecast period.
Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/312
Companies Profiled:
• F. Hoffmann-La Roche AG,
• Merck & Co., Inc.,
• Novartis International AG,
• Johnson & Johnson,
• GlaxoSmithKline PLC,
• Amgen Inc,
• AstraZeneca PLC,
• Bristol-Myers Squibb,
• Galena Biopharma,
• Inovio Pharmaceuticals.
Key topics covered:
1. Preface
2. Executive Summary
3. Global Immunotherapy Market Overview
4. Global Immunotherapy Market Analysis, by Product (USD Million) 2017 – 2023
5. Global Immunotherapy Market Analysis, by Disease Condition (USD Million) 2017 – 2023
6. Global Immunotherapy Market Analysis, by Region (USD Million) 2017 – 2023
7. Company Profiles
Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/immunotherapy_drugs_market